Latest Governance News

Veris Limited has reported a significant turnaround in FY25, posting a $2 million profit before tax on $97.2 million revenue, driven by growth in digital and spatial advisory services and strategic acquisitions.

Veris Limited has returned to profitability in FY25, driven by strong growth in its digital and spatial advisory services, while declaring its first dividend in years and strengthening its cash position.

Veris Limited has reported a significant financial turnaround for the year ended June 2025, returning to profitability and boosting earnings, while strategically acquiring Spatial Vision to broaden its geospatial services across Australia.

Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.

Cedar Woods Properties Limited delivered a robust FY25 with a 19% increase in net profit, underpinned by a diversified project portfolio and favourable market conditions. The company signals continued growth with a 10% NPAT guidance for FY26, supported by strong presales and strategic partnerships.

Cedar Woods Properties has reported a robust 19% rise in net profit for FY25, surpassing guidance with strong presales and strategic partnerships setting the stage for continued growth.

AUB Group Limited delivered a robust FY25 performance, with underlying NPAT rising 17.1% to AUD 200.2 million, driven by strategic acquisitions and margin improvements. The company’s aggressive UK retail expansion and diversified portfolio underpin a confident FY26 outlook.

AUB Group Limited has reported a robust FY25 financial performance, highlighted by a 171% increase in underlying net profit after tax and a 15.2% rise in total dividends. Strategic acquisitions and organic growth across divisions underpin the company’s strong momentum.

NZME Limited reported a 3.1% revenue decline for H1 2025 but delivered a 12% rise in operating EBITDA, driven by digital growth and cost efficiencies. The company declared a 3 cent interim dividend amid ongoing economic challenges.

Metals X Limited reported a robust half-year to June 2025 with profit after tax soaring 256% to $52.9 million, driven by higher tin sales and prices from its Renison joint venture. The company also progressed key projects and deepened strategic investments while reinforcing its ESG and safety frameworks.

Acrow Limited reports a record FY25 with sales up 23%, driven by an 83% jump in its Industrial Access division, now half of group revenue. Despite soft formwork markets, strategic acquisitions and growth initiatives underpin a confident outlook.

Actinogen Medical reported a $14.7 million net loss for FY25 while progressing its lead drug Xanamem through pivotal Alzheimer’s and depression trials, with interim results expected in January 2026. The company has secured funding through mid-2026 and is preparing for commercialization.